Benzinga24 Ağustos 2026 22:45 TR10 gün önce

$100 Invested In Regeneron Pharmaceuticals 15 Years Ago Would Be Worth This Much Today

Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 15 years by 6.17% on an annualized basis producing an average annual return of 19.2%. Currently, Regeneron Pharmaceuticals has a market

Haberin Tamamı Kaynağında

Burada gördüğün özet, haber sağlayıcısından geliyor; metnin devamı yayıncının sitesinde — Benzinga

Kaynakta Oku

Haberde Geçen Şirketler

REGNRegeneron Pharmaceuticals Inc833,11− %1,23

Benzer Haberler

The trading volume of these stocks is deviating from the norm in today's session.
ChartMill59 dakika önce
Discover which S&P500 stocks are making waves on Friday.
ChartMill1 saat önce
Sodexo : Monthly disclosure on share capital and voting rights August 31, 2026
Yahoo2 saat önce
ANF vs. TPR: Which Stock Is the Better Value Option?
Yahoo2 saat önce
Anthropic's IPO Push Just Got a $15 Billion Backstop
Yahoo2 saat önce